Trial Profile
Targeting of the Small Airways in Patients With COPD: Airway Effects of Tiotropium - Respimat vs Handihaler
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Nov 2019
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 07 Nov 2019 Status changed from recruiting to completed.
- 03 Mar 2019 This trial has been completed in UK according to European Clinical Trials Database.
- 17 May 2016 Status changed from not yet recruiting to recruiting.